In this episode, ‘Managing Treatment Failure in Psoriasis,’ the expert dermatologists focus on the practical management of treatment failure in psoriasis. The faculty discussed how to differentiate between primary non-response and secondary loss of response, emphasizing that these scenarios require distinct clinical approaches. Rather than immediately discontinuing therapy, clinicians are encouraged to assess disease patterns, patient satisfaction, and treatment adherence in patients with psoriasis.

They discuss the value of maintaining open communication with patients, particularly when evaluating treatment success. Even when clinical improvement is observed, patient perception of disease control remains critical in guiding next steps. The panelists highlight that some patients may be satisfied with partial improvement, while others may seek more complete clearance, reinforcing the need for shared decision-making.

The panelists explore strategies for managing suboptimal response include optimizing current therapy with adjunctive treatments, switching within the same biologic class, or transitioning to a different mechanism of action. They also introduce the concept of multi-biologic failure, where patients experience diminishing responses across multiple therapies. They raise the question of whether initiating treatment with the most effective therapy upfront may improve long-term outcomes and reduce the risk of treatment resistance. The faculty emphasize a proactive and flexible approach to treatment optimization, with the goal of achieving sustained disease control.

The next episode in this series, ‘Implementing Remission Goals in Psoriasis Practice,’ features the panelists highlighting practical approaches to implementing remission-focused care in psoriasis, emphasizing that achieving and maintaining clear skin is an attainable goal. It reinforces the importance of setting expectations, using simple assessment tools, and confidently selecting effective therapies to optimize patient outcomes.